Angiogenic Acceleration of Neu Induced Mammary Tumor Progression and Metastasis
暂无分享,去创建一个
R. Cardiff | C. Hauser | W. Muller | J. Lesperance | L. Hebbard | B. Ranscht | R. Oshima | N. Sharan | V. Munoz | Jacqueline Lesperance
[1] P. Argani,et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast , 2003, Oncogene.
[2] M. Bissell,et al. Polarity determination in breast tissue: desmosomal adhesion, myoepithelial cells, and laminin 1 , 2003, Breast Cancer Research.
[3] P. Chambon,et al. Expression of conditional cre recombinase in epithelial tissues of transgenic mice , 2003, Genesis.
[4] C. White,et al. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex , 2002, The Journal of cell biology.
[5] Nijole Gasiunas,et al. Neuropilin-1 Binds Vascular Endothelial Growth Factor 165, Placenta Growth Factor-2, and Heparin via Its b1b2 Domain* , 2002, The Journal of Biological Chemistry.
[6] T. Sugino,et al. An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. , 2002, The American journal of pathology.
[7] Y. Q. Chen,et al. Peptidylprolyl isomerase A (PPIA) as a preferred internal control over GAPDH and beta-actin in quantitative RNA analyses. , 2002, BioTechniques.
[8] D. Hanahan,et al. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. , 2002, Cancer cell.
[9] G. Christofori,et al. Overexpression of Vascular Endothelial Growth Factor-a165 Updated Version Cited Articles Citing Articles E-mail Alerts Overexpression of Vascular Endothelial Growth Factor-a165 Enhances Tumor Angiogenesis but Not Metastasis during -cell Carcinogenesis , 2013 .
[10] W. Muller,et al. Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins* , 2001, The Journal of Biological Chemistry.
[11] M. Bissell,et al. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini , 2001, Nature Cell Biology.
[12] L. Shaw,et al. Advances in Brief Vascular Endothelial Growth Factor Is an Autocrine Survival Factor for Neuropilin-expressing Breast Carcinoma Cells 1 , 2001 .
[13] G. Semenza,et al. HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression , 2001, Molecular and Cellular Biology.
[14] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[15] M. Moran,et al. Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer , 2001, Molecular and Cellular Biology.
[16] S. Sadekova,et al. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor , 2001, Oncogene.
[17] K. Alitalo,et al. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis , 2000, Oncogene.
[18] R. Johnson,et al. Isoforms of Vascular Endothelial Growth Factor Act in a Coordinate Fashion To Recruit and Expand Tumor Vasculature , 2000, Molecular and Cellular Biology.
[19] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[20] Stanley J. Wiegand,et al. Vascular-specific growth factors and blood vessel formation , 2000, Nature.
[21] R. Klemenz,et al. Advances in Brief Increased Expression of H/T-Cadherin in Tumor-penetrating Blood Vessels 1 , 2022 .
[22] S. Mader,et al. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis , 2000, Oncogene.
[23] D Bilder,et al. Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. , 2000, Science.
[24] W. Muller,et al. Mammary gland neoplasia: insights from transgenic mouse models , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[25] N. Ahn,et al. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. , 2000, Cancer Research.
[26] S Rozen,et al. Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.
[27] Thomas N. Sato,et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.
[28] D. Hanahan,et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.
[29] G. Yancopoulos,et al. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. , 1999, Genes & development.
[30] R. Cardiff,et al. Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer , 1999, The EMBO journal.
[31] G. Semenza,et al. Oncogenic alterations of metabolism. , 1999, Trends in biochemical sciences.
[32] M. Karkkainen,et al. Overexpression of VEGF in Testis and Epididymis Causes Infertility in Transgenic Mice: Evidence for Nonendothelial Targets for VEGF , 1998, Journal of Cell Biology.
[33] P. Bryant,et al. Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. , 1998, The American journal of pathology.
[34] W. Wahli,et al. Printed in U.S.A. Copyright © 1998 by The Endocrine Society Differential Expression of Peroxisome Proliferator- Activated Receptor-�,-�, and- � during Rat , 2022 .
[35] Jessica Lo,et al. HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .
[36] John N. Hutchinson,et al. Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis , 1998, Molecular and Cellular Biology.
[37] Z. Werb,et al. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752] , 1994, The Journal of cell biology.
[38] Y. Ebina,et al. Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. , 1992, The Journal of biological chemistry.
[39] B. Ranscht,et al. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region , 1991, Neuron.
[40] D. Hanahan,et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.
[41] P. Leder,et al. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.
[42] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[43] R. Oshima,et al. Preimplantation mouse embryos and liver express the same type I keratin gene product. , 1985, The Journal of biological chemistry.
[44] H. Bern,et al. The effect of hormones on the vascular pattern of the mouse mammary gland. , 1958, The American journal of anatomy.